Introduction {#sec1_1}
============

The numbers of dialysis patients and facilities in Southeast Asian developing countries have increased substantially, but precise data are unavailable. There have not been any reports about dialysate quality in these countries. In this study, the number of dialysis patients and related statistical data were collected from these countries. The dialysate quality survey was carried out at multiple dialysis facilities in Vietnam and Cambodia.

Study 1 aimed to assess the current status of dialysis practice in Southeast Asian developing countries. Study 2 aimed to investigate the quality of dialysates used at dialysis facilities in Vietnam and Cambodia.

Subjects and Methods {#sec1_2}
====================

Study 1 {#sec2_1}
-------

A survey of the status of dialysis in Southeast Asian countries as of July 1, 2011, was carried out with the support of 9 Japanese dialysis-related companies which have overseas marketing channels. Each company was asked to fill out the survey form on the basis of local information collected by the company. The survey included the numbers of dialysis facilities and patients receiving dialysis in each country, a ranking of underlying diseases causing the initiation of dialysis, the number of patients receiving hemodialysis (HD)/on-line hemodiafiltration (HDF)/continuous ambulatory peritoneal dialysis (CAPD), the number of HD machines (consoles) installed, the cost of each session of dialysis (in USD), the percentage of out-of-pocket payments, and the 1-year survival rates of the dialysis patients (in percent).

Study 2 {#sec2_2}
-------

A survey team, including an expert in dialysate purification, was sent for a period from July 31 to August 7, 2011, to investigate the quality of dialysates used at local dialysis facilities, with the cooperation of 3 Vietnamese facilities (facilities A-C) and 1 Cambodian facility (facility D). The survey covered the endotoxin (ET) level \[ET units (EU) per liter\] and bacterial count \[colony-forming units (CFU) per milliliter\] in tap water, in water filtered through a reverse osmosis (RO) system and in dialysate. At facilities A, B and C, ET was measured on site. At facility D, samples were collected and combined with a preservative (to minimize ET inactivation), and these samples were carried back to Japan for measurement of ET. The bacterial count was analyzed on the pictures sent via e-mail by a local physician who had photographed the culture medium inoculated with the sample using a digital camera.

The device used for ET measurement was a Toxinometer Mini (Wako Pure Chemical Industries Ltd., Osaka, Japan) in combination with the ET measurement reagent Limulus ES-II Single Test Wako (Wako Pure Chemical Industries). Sampling involved a Contamiless Sampling Port (Medicalseed Co. Ltd., Nobeoka, Japan) and a 1-ml syringe for diabetes (supplied by the local facility; manufacturer unknown). The sample (0.2 ml) was combined with the reagent for measurement. The detectable limit was 0.001 EU/ml (= 1 EU/l). Measurement was done by the turbidimetric method.

The R2A culture medium used was BBL R2A Agar (Becton, Dickinson and Co., USA). The half-dried sample (1 ml) was applied to the medium, followed by 2 weeks of incubation at room temperature (23-28°C). The colonies were then counted.

Results {#sec1_3}
=======

Study 1 {#sec2_3}
-------

As shown in table [1](#T1){ref-type="table"}, the number of dialysis facilities in Asia has increased. In developed Asian countries such as Japan, Taiwan and Korea, the proportion of patients receiving dialysis has reached 0.1-0.2% of the population. In Cambodia, there were only 2 dialysis facilities as of March 2010 (located in Phnom Penh only), but their number increased to 10 during the subsequent year. In each country, the most frequent cause of renal failure resulting in the initiation of dialysis is diabetes mellitus, as shown in table [2](#T2){ref-type="table"}. On-line HDF has been spreading not only in developed but also developing countries. The exact number of patients receiving on-line HDF in Japan is unknown because no survey focusing specifically on on-line HDF has been carried out. In each of the countries, CAPD is not as widespread as HD (tables [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}). The cost of each session of dialysis and the percentages of out-of-pocket payments vary among the countries, but the expenses tend to be higher in the developed countries. In the developing countries, such as Cambodia and Vietnam, HD is usually carried out according to the 'reuse' principle. The cost of dialysis is affected by the presence or absence of reuse. The cost of CAPD is higher in the developed countries as the price of the CAPD device/materials is determined by the economic status of the individual countries. The cost of CAPD is quite high in Japan (table [5](#T5){ref-type="table"}). The 1-year survival rate of dialysis patients is slightly lower than 90% in the developed countries. Data on 1-year survival are unavailable in many countries. The rate is 70% in Myanmar and about 90% in the Philippines and Malaysia (table [6](#T6){ref-type="table"}). The dialyzer was reused in all the developing countries. Japan, Korea and Taiwan followed a dialyzer single-use principle.

Study 2 {#sec2_4}
-------

As reference information, the dialysate quality standards prepared by the Japanese Society for Dialysis Therapy are presented below \[[@B1]\]. In RO water and standard dialysate, the ET level should be \<50 EU/l and the bacterial count \<100 CFU/ml. In ultrapure dialysate injected directly into the human body (e.g. for on-line HDF), the ET level should be \<1 EU/l (less than the detectable limit) and the bacterial count \<0.1 CFU/ml.

When compared with the standard levels given above, the ET levels in RO water were acceptable at 2 facilities during the present survey. Because no on-line HDF and high-performance dialyzers were used at the facilities investigated, ET levels in dialysis fluids were assessed only on standard dialysis. The ET levels in standard dialysates were satisfactory only at facility B. The bacterial counts in RO water were acceptable only at facility C. The bacterial counts in dialysates were not acceptable at any of the facilities investigated (table [7](#T7){ref-type="table"}).

Discussion {#sec1_4}
==========

Study 1 revealed that dialysis therapy has been rapidly spreading in Asian countries. As pointed out previously, the numbers of dialysis facilities and patients receiving dialysis seem to be proportional to the gross domestic product. The number of dialysis patients is smaller in poorer countries \[[@B2],[@B3]\]. However, even in countries like Cambodia where this was previously considered unlikely or impossible, dialysis therapy has been spreading steadily. The recent economic growth in Southeast Asian countries has been remarkable. In Vietnam, a national health insurance system is available, with the percentage of out-of-pocket payments being 0%. Study 2 reveals that these developing countries need to acquire considerable know-how about water purification. A low quality of dialysates has many disadvantages for dialysis patients \[[@B4],[@B5],[@B6]\]. As soon as possible, detailed know-how about how to purify dialysates should be taught to medical workers conducting dialyses by personnel who are specially trained to manage the relevant medical machines and devices in these developing countries. Training courses should be established for clinical engineers working in dialysis units.

###### 

Number of dialysis facilities and patients

                Patients, n   Percentage of population   Facilities, n
  ------------- ------------- -------------------------- ---------------
  Cambodia      200           0.001                      10
  Myanmar       600           0.001                      28
  Philippines   10,000        0.011                      270
  Vietnam       14,000        0.015                      130
  Malaysia      23,500        0.083                      600
  Thailand      29,500        0.044                      500
  Korea         45,009        0.093                      614
  Taiwan        63,655        0.275                      552
  China         272,000       0.020                      3,500
  Japan         297,126       0.232                      4,152

###### 

The three most frequent diseases causing initiation of dialysis

                1st       2nd       3rd
  ------------- --------- --------- ------------------------
  Cambodia      DM        CGN       --
  Myanmar       HT        DM        CGN
  Philippines   DM        HT        kidney injury
  Vietnam       unknown   unknown   unknown
  Malaysia      DM        unknown   HT
  Thailand      DM        CGN       unknown
  Korea         DM        HT        CGN
  Taiwan        DM        CGN       interstitial nephritis
  China         CGN       DM        HT
  Japan         DM        CGN       nephrosclerosis

DM = Diabetes mellitus; CGN = chronic glomerulonephritis; HT = hypertension.

###### 

Numbers of patients on HD, on-line HDF and CAPD

                HD        On-line HDF   CAPD
  ------------- --------- ------------- --------
  Cambodia      200       0             0
  Myanmar       600       0             0
  Philippines   9,300     Unknown       700
  Vietnam       10,000    5--10         2,000
  Malaysia      21,700    Unknown       1,800
  Thailand      26,500    1,400         1,500
  Korea         37,391    4,000         7,618
  Taiwan        55,825    2,200         6,110
  China         260,000   Unknown       12,000
  Japan         297,126   Unknown       9,728

###### 

Numbers of HD and on-line HDF consoles

                HD consoles   On-line HDF consoles
  ------------- ------------- ----------------------
  Cambodia      75            0
  Myanmar       130           0
  Philippines   1,870         70
  Vietnam       2,000         3
  Malaysia      6,500         unknown
  Thailand      5,000         250
  Korea         33,900        500
  Taiwan        15,040        430
  China         30,000        unknown
  Japan         118,135       unknown

###### 

Cost of dialysis (USD) and percentage of out-of-pocket payments

                HD (per session)   CAPD (monthly)   Percentage of out-of-pocket payments
  ------------- ------------------ ---------------- --------------------------------------
  Cambodia      55                 570              100
  Myanmar       55                 750              100
  Philippines   50                 240              80
  Vietnam       30                 300              0
  Malaysia      50                 unknown          0
  Thailand      25                 500              0--25
  Korea         130                1,200            10
  Taiwan        170                2,000            0
  China         90                 800              5--30
  Japan         350                5,000            0

###### 

One-year survival rate (%)

                HD                        CAPD
  ------------- ------------------------- -------------
  Cambodia      unknown                   not started
  Myanmar       70                        70
  Philippines   90                        90
  Vietnam       unknown                   unknown
  Malaysia      89                        87
  Thailand      unknown                   unknown
  Korea         94                        94
  Taiwan        87.5                      89.8
  China         unknown                   unknown
  Japan         87.4 (both HD and CAPD)   

###### 

Quality of tap water, RO water and dialysates

                                                  ET, EU/l   Bacteria, CFU/ml
  ----------------------------------------------- ---------- ------------------
  Facility A                                                 
   Tap water                                      8,076      200
   RO water                                       57         100
   Dialysate 1                                    741        500
   Dialysate 2                                    903        800
  Facility B                                                 
   Tap water                                      378        70
   RO water                                       2.9        300
   Dialysate 1                                    38         150
   Dialysate 2                                    49         100
  Facility C                                                 
   Tap water                                      1,468      110
   RO water                                       94         22
   Dialysate 1                                    201        600
   Dialysate 2                                    395        1,000
   Dialysate 3[^a^](#T7F1){ref-type="table-fn"}   2,295      1,000
  Facility D                                                 
   Tap water                                      1,663      110
   RO water 1                                     7.3        120
   RO water 2                                     7.8        100
   Dialysate 1                                    309        800
   Dialysate 2                                    246        800

At a console with an ET-retentive filter.
